Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 297


Optical imaging with a novel cathepsin-activatable probe for enhanced detection of colorectal cancer.

Esfahani SA, Heidari P, Kucherlapati MH, Ferrer JM, Kucherlapati RS, Mahmood U.

Am J Nucl Med Mol Imaging. 2019 Oct 15;9(5):230-242. eCollection 2019.


Management implications of fluorodeoxyglucose positron emission tomography/magnetic resonance in untreated intrahepatic cholangiocarcinoma.

Ferrone C, Goyal L, Qadan M, Gervais D, Sahani DV, Zhu AX, Hong TS, Blaszkowsky LS, Tanabe KK, Vangel M, Amorim BJ, Wo JY, Mahmood U, Pandharipande PV, Catana C, Duenas VP, Collazo YQ, Canamaque LG, Domachevsky L, Bernstine HH, Groshar D, Shih TT, Li Y, Herrmann K, Umutlu L, Rosen BR, Catalano OA.

Eur J Nucl Med Mol Imaging. 2019 Dec 11. doi: 10.1007/s00259-019-04558-3. [Epub ahead of print]


Dual energy computed tomography analysis in cancer patients: What factors affect iodine concentration in contrast enhanced studies?

Corrias G, Sawan P, Mahmood U, Zheng J, Capanu M, Salvatore M, Spinato G, Saba L, Mannelli L.

Eur J Radiol. 2019 Nov;120:108698. doi: 10.1016/j.ejrad.2019.108698. Epub 2019 Oct 3.


Patient-Specific Organ and Effective Dose Estimates in Adult Oncologic CT.

Gao Y, Mahmood U, Liu T, Quinn B, Gollub MJ, Xu XG, Dauer LT.

AJR Am J Roentgenol. 2019 Aug 15:1-9. doi: 10.2214/AJR.19.21197. [Epub ahead of print]


Clinical impact of PET/MR in treated colorectal cancer patients.

Amorim BJ, Hong TS, Blaszkowsky LS, Ferrone CR, Berger DL, Bordeianou LG, Ricciardi R, Clark JW, Ryan DP, Wo JY, Qadan M, Vangel M, Umutlu L, Groshar D, Cañamaques LG, Gervais DA, Mahmood U, Rosen BR, Catalano OA.

Eur J Nucl Med Mol Imaging. 2019 Oct;46(11):2260-2269. doi: 10.1007/s00259-019-04449-7. Epub 2019 Jul 29.


Salivary HPV DNA informs locoregional disease status in advanced HPV-associated oropharyngeal cancer.

Hanna GJ, Lau CJ, Mahmood U, Supplee JG, Mogili AR, Haddad RI, Jänne PA, Paweletz CP.

Oral Oncol. 2019 Aug;95:120-126. doi: 10.1016/j.oraloncology.2019.06.019. Epub 2019 Jun 20.


Neuroepigenetic signatures of age and sex in the living human brain.

Gilbert TM, Zürcher NR, Catanese MC, Tseng CJ, Di Biase MA, Lyall AE, Hightower BG, Parmar AJ, Bhanot A, Wu CJ, Hibert ML, Kim M, Mahmood U, Stufflebeam SM, Schroeder FA, Wang C, Roffman JL, Holt DJ, Greve DN, Pasternak O, Kubicki M, Wey HY, Hooker JM.

Nat Commun. 2019 Jul 3;10(1):2945. doi: 10.1038/s41467-019-11031-0.


A Phase 1 Study of Afatinib in Combination with Postoperative Radiation Therapy with and Without Weekly Docetaxel in Intermediate- and High-Risk Patients with Resected Squamous Cell Carcinoma of the Head and Neck.

Margalit DN, Haddad RI, Tishler RB, Chau NG, Schoenfeld JD, Bakst RL, Misiukiewicz KJ, Gupta V, Posner M, Hanna GJ, Mahmood U, Rawal B, Catalano PJ, Rath L, Bacay A, McHugh P, Rabinowits G.

Int J Radiat Oncol Biol Phys. 2019 Sep 1;105(1):132-139. doi: 10.1016/j.ijrobp.2019.04.034. Epub 2019 May 11.


Correction: 18F-Fluoroestradiol PET/CT Measurement of Estrogen Receptor Suppression during a Phase I Trial of the Novel Estrogen Receptor-Targeted Therapeutic GDC-0810: Using an Imaging Biomarker to Guide Drug Dosage in Subsequent Trials.

Wang Y, Ayres KL, Goldman DA, Dickler MN, Bardia A, Mayer IA, Winer E, Fredrickson J, Arteaga CL, Baselga J, Manning HC, Mahmood U, Ulaner GA.

Clin Cancer Res. 2019 Feb 15;25(4):1435. doi: 10.1158/1078-0432.CCR-18-4266. No abstract available.


Inhibition of de novo lipogenesis targets androgen receptor signaling in castration-resistant prostate cancer.

Zadra G, Ribeiro CF, Chetta P, Ho Y, Cacciatore S, Gao X, Syamala S, Bango C, Photopoulos C, Huang Y, Tyekucheva S, Bastos DC, Tchaicha J, Lawney B, Uo T, D'Anello L, Csibi A, Kalekar R, Larimer B, Ellis L, Butler LM, Morrissey C, McGovern K, Palombella VJ, Kutok JL, Mahmood U, Bosari S, Adams J, Peluso S, Dehm SM, Plymate SR, Loda M.

Proc Natl Acad Sci U S A. 2019 Jan 8;116(2):631-640. doi: 10.1073/pnas.1808834116. Epub 2018 Dec 21.


Code of ethics for the American Association of Physicists in Medicine (Revised): Report of Task Group 109.

Skourou C, Sherouse GW, Bahar N, Bauer LA, Fairobent L, Freedman DJ, Genovese LM, Halvorsen PH, Kirby NA, Mahmood U, Ozturk N, Osterman KS, Serago CF, Svatos MM, Wilson ML.

Med Phys. 2019 Apr;46(4):e79-e93. doi: 10.1002/mp.13351. Epub 2019 Feb 13.


Normal Correction of Sodium Leading to Central Pontine Demyelinosis: A Rare Occurrence.

Siddiqui FS, Javed Z, Mahmood U, Saeed I, Qasim YF, Saeed MSB.

Cureus. 2018 Sep 4;10(9):e3252. doi: 10.7759/cureus.3252.


The Effectiveness of Checkpoint Inhibitor Combinations and Administration Timing Can Be Measured by Granzyme B PET Imaging.

Larimer BM, Bloch E, Nesti S, Austin EE, Wehrenberg-Klee E, Boland G, Mahmood U.

Clin Cancer Res. 2019 Feb 15;25(4):1196-1205. doi: 10.1158/1078-0432.CCR-18-2407. Epub 2018 Oct 16.


What Can Be Done to Improve Research Biopsy Quality in Oncology Clinical Trials?

Ferry-Galow KV, Datta V, Makhlouf HR, Wright J, Wood BJ, Levy E, Pisano ED, Tam AL, Lee SI, Mahmood U, Rubinstein LV, Doroshow JH, Chen AP.

J Oncol Pract. 2018 Oct 4:JOP1800092. doi: 10.1200/JOP.18.00092. [Epub ahead of print]


The Impact of Positron Emission Tomography with 18F-Fluciclovine on the Treatment of Biochemical Recurrence of Prostate Cancer: Results from the LOCATE Trial.

Andriole GL, Kostakoglu L, Chau A, Duan F, Mahmood U, Mankoff DA, Schuster DM, Siegel BA; LOCATE Study Group.

J Urol. 2019 Feb;201(2):322-331. doi: 10.1016/j.juro.2018.08.050.


Lower Gastrointestinal Tract Applications of PET/Computed Tomography and PET/MR Imaging.

Catalano O, Kilcoyne A, Signore A, Mahmood U, Rosen B.

Radiol Clin North Am. 2018 Sep;56(5):821-834. doi: 10.1016/j.rcl.2018.05.001. Review.


Phloroglucinol ameliorates cognitive impairments by reducing the amyloid β peptide burden and pro-inflammatory cytokines in the hippocampus of 5XFAD mice.

Yang EJ, Mahmood U, Kim H, Choi M, Choi Y, Lee JP, Cho JY, Hyun JW, Kim YS, Chang MJ, Kim HS.

Free Radic Biol Med. 2018 Oct;126:221-234. doi: 10.1016/j.freeradbiomed.2018.08.016. Epub 2018 Aug 15.


Plasma HPV cell-free DNA monitoring in advanced HPV-associated oropharyngeal cancer.

Hanna GJ, Supplee JG, Kuang Y, Mahmood U, Lau CJ, Haddad RI, Jänne PA, Paweletz CP.

Ann Oncol. 2018 Sep 1;29(9):1980-1986. doi: 10.1093/annonc/mdy251.


Comparison of the clinical performance of upper abdominal PET/DCE-MRI with and without concurrent respiratory motion correction (MoCo).

Catalano OA, Umutlu L, Fuin N, Hibert ML, Scipioni M, Pedemonte S, Vangel M, Catana AM, Herrmann K, Nensa F, Groshar D, Mahmood U, Rosen BR, Catana C.

Eur J Nucl Med Mol Imaging. 2018 Nov;45(12):2147-2154. doi: 10.1007/s00259-018-4084-2. Epub 2018 Jul 11.


Somatostatin receptor type 2 as a radiotheranostic PET reporter gene for oncologic interventions.

Heidari P, Kunawudhi A, Martinez-Quintanilla J, Szretter A, Shah K, Mahmood U.

Theranostics. 2018 May 23;8(12):3380-3391. doi: 10.7150/thno.24017. eCollection 2018.


C11 Methionine PET (MET-PET) Imaging of Glioblastoma for Detecting Postoperative Residual Disease and Response to Chemoradiation Therapy.

Wang Y, Rapalino O, Heidari P, Loeffler J, Shih HA, Oh K, Mahmood U.

Int J Radiat Oncol Biol Phys. 2018 Nov 15;102(4):1024-1028. doi: 10.1016/j.ijrobp.2018.06.011. Epub 2018 Jun 18.


Specific 18F-FDHT Accumulation in Human Prostate Cancer Xenograft Murine Models Is Facilitated by Prebinding to Sex Hormone-Binding Globulin.

Larimer BM, Dubois F, Bloch E, Nesti S, Placzek M, Zadra G, Hooker JM, Loda M, Mahmood U.

J Nucl Med. 2018 Oct;59(10):1538-1543. doi: 10.2967/jnumed.118.208785. Epub 2018 May 31.


The Role of Imaging in Prostate Cancer Care Pathway: Novel Approaches to Urologic Management Challenges Along 10 Imaging Touch Points.

Li Q, Xiang F, Lin X, Grajo JR, Yang L, Xu Y, Duan Y, Vyas U, Harisinghani M, Mahmood U, Samir AE.

Urology. 2018 Sep;119:23-31. doi: 10.1016/j.urology.2018.04.026. Epub 2018 May 3. Review.


Clinicopathological Characteristics of Prostate Cancer in Patients Presenting to a Tertiary Care Private Sector Hospital.

Masood A, Iqbal N, Shohab D, Hasan A, Aimon S, Mahmood U, Akhter S.

J Coll Physicians Surg Pak. 2018 May;28(5):409-411. doi: 10.29271/jcpsp.2018.05.409.


Rapid switching kVp dual energy CT: Value of reconstructed dual energy CT images and organ dose assessment in multiphasic liver CT exams.

Mahmood U, Horvat N, Horvat JV, Ryan D, Gao Y, Carollo G, DeOcampo R, Do RK, Katz S, Gerst S, Schmidtlein CR, Dauer L, Erdi Y, Mannelli L.

Eur J Radiol. 2018 May;102:102-108. doi: 10.1016/j.ejrad.2018.02.022. Epub 2018 Feb 19.


In-vitro evaluation and in-silico studies applied on newly synthesized amide derivatives of N-phthaloylglycine as Butyrylcholinesterase (BChE) inhibitors.

Begum S, Nizami SS, Mahmood U, Masood S, Iftikhar S, Saied S.

Comput Biol Chem. 2018 Jun;74:212-217. doi: 10.1016/j.compbiolchem.2018.04.003. Epub 2018 Apr 7.


Exradin W1 plastic scintillation detector for in vivo skin dosimetry in passive scattering proton therapy.

Alsanea F, Wootton L, Sahoo N, Kudchadker R, Mahmood U, Beddar S.

Phys Med. 2018 Mar;47:58-63. doi: 10.1016/j.ejmp.2018.02.014. Epub 2018 Feb 27.


Diagnostic performance of PET/MR in the evaluation of active inflammation in Crohn disease.

Catalano OA, Wu V, Mahmood U, Signore A, Vangel M, Soricelli A, Salvatore M, Gervais D, Rosen BR.

Am J Nucl Med Mol Imaging. 2018 Feb 5;8(1):62-69. eCollection 2018.


Quantification of Iodine Concentration Using Single-Source Dual-Energy Computed Tomography in a Calf Liver.

Agostini A, Mahmood U, Erdi Y, Borgheresi A, Ragucci M, Sawan P, Ryan D, Laino ME, Corrias G, Mannelli L.

J Comput Assist Tomogr. 2018 Mar/Apr;42(2):222-229. doi: 10.1097/RCT.0000000000000685.


Patient-specific organ and effective dose estimates in pediatric oncology computed tomography.

Gao Y, Quinn B, Pandit-Taskar N, Behr G, Mahmood U, Long D, Xu XG, St Germain J, Dauer LT.

Phys Med. 2018 Jan;45:146-155. doi: 10.1016/j.ejmp.2017.12.013. Epub 2017 Dec 22.


Transient Anosmia Induces Depressive-like and Anxiolytic-like Behavior and Reduces Amygdalar Corticotropin-Releasing Hormone in a ZnSO4-Induced Mouse Model.

Ahn S, Choi M, Kim H, Yang EJ, Mahmood U, Kang SI, Shin HW, Kim DW, Kim HS.

Chem Senses. 2018 Apr 23;43(4):213-221. doi: 10.1093/chemse/bjy008.


Radiotheranostics in Cancer Diagnosis and Management.

Jadvar H, Chen X, Cai W, Mahmood U.

Radiology. 2018 Feb;286(2):388-400. doi: 10.1148/radiol.2017170346. Review.


Spectrum (characteristics) of patients with chronic kidney disease (CKD) with increasing age in a major metropolitan renal service.

Mahmood U, Healy HG, Kark A, Cameron A, Wang Z, Abeysekera R, Hoy WE.

BMC Nephrol. 2017 Dec 28;18(1):372. doi: 10.1186/s12882-017-0781-5.


Patient-reported health-related quality of life for men treated with low-dose-rate prostate brachytherapy as monotherapy with 125-iodine, 103-palladium, or 131-cesium: Results of a prospective phase II study.

Blanchard P, Pugh TJ, Swanson DA, Mahmood U, Chen HC, Wang X, Graber WJ, Kudchadker RJ, Bruno T, Feeley T, Frank SJ.

Brachytherapy. 2018 Mar - Apr;17(2):265-276. doi: 10.1016/j.brachy.2017.11.007. Epub 2017 Dec 18.


Prospective Phase 2 Trial of Permanent Seed Implantation Prostate Brachytherapy for Intermediate-Risk Localized Prostate Cancer: Efficacy, Toxicity, and Quality of Life Outcomes.

Frank SJ, Pugh TJ, Blanchard P, Mahmood U, Graber WJ, Kudchadker RJ, Davis JW, Kim J, Choi H, Troncoso P, Kuban DA, Choi S, McGuire S, Hoffman KE, Chen HC, Wang X, Swanson DA.

Int J Radiat Oncol Biol Phys. 2018 Feb 1;100(2):374-382. doi: 10.1016/j.ijrobp.2017.09.050. Epub 2017 Oct 12.


Sodium fluoride PET imaging as a quantitative pharmacodynamic biomarker for bone homeostasis during anti-DKK1 therapy for multiple myeloma.

Wang Y, Yee AJ, Sirard C, Landau S, Raje N, Mahmood U.

Blood Cancer J. 2017 Oct 6;7(10):e615. doi: 10.1038/bcj.2017.95. No abstract available.


Quality of life after brachytherapy or bilateral nerve-sparing robot-assisted radical prostatectomy for prostate cancer: a prospective cohort.

Blanchard P, Davis JW, Frank SJ, Kim J, Pettaway CA, Pugh TJ, Pisters LL, Ward JF, Choi S, Chapin BF, Hoffman K, Navai N, Achim M, McGuire SE, Matin SF, Nguyen Q, Mahmood U, Graber WJ, Chen HC, Wang X, Kuban DA.

BJU Int. 2018 Apr;121(4):540-548. doi: 10.1111/bju.14021. Epub 2017 Oct 17.


Dendritic spine anomalies and PTEN alterations in a mouse model of VPA-induced autism spectrum disorder.

Mahmood U, Ahn S, Yang EJ, Choi M, Kim H, Regan P, Cho K, Kim HS.

Pharmacol Res. 2018 Feb;128:110-121. doi: 10.1016/j.phrs.2017.08.006. Epub 2017 Aug 18.


Radiological Tenckhoff catheter insertion for peritoneal dialysis: A cost-effective approach.

Lee J, Mott N, Mahmood U, Clouston J, Summers K, Nicholas P, Gois PHF, Ranganathan D.

J Med Imaging Radiat Oncol. 2018 Apr;62(2):174-178. doi: 10.1111/1754-9485.12643. Epub 2017 Aug 1.


Phage Display Selection, In Vitro Characterization, and Correlative PET Imaging of a Novel HER3 Peptide.

Larimer BM, Phelan N, Wehrenberg-Klee E, Mahmood U.

Mol Imaging Biol. 2018 Apr;20(2):300-308. doi: 10.1007/s11307-017-1106-6.


Association between intensity modulated radiotherapy and survival in patients with stage III non-small cell lung cancer treated with chemoradiotherapy.

Koshy M, Malik R, Spiotto M, Mahmood U, Rusthoven CG, Sher DJ.

Lung Cancer. 2017 Jun;108:222-227. doi: 10.1016/j.lungcan.2017.04.006. Epub 2017 Apr 17.


Synthesis and preliminary PET imaging of 11C and 18F isotopologues of the ROS1/ALK inhibitor lorlatinib.

Collier TL, Normandin MD, Stephenson NA, Livni E, Liang SH, Wooten DW, Esfahani SA, Stabin MG, Mahmood U, Chen J, Wang W, Maresca K, Waterhouse RN, El Fakhri G, Richardson P, Vasdev N.

Nat Commun. 2017 Jun 8;8:15761. doi: 10.1038/ncomms15761.


Staging performance of whole-body DWI, PET/CT and PET/MRI in invasive ductal carcinoma of the breast.

Catalano OA, Daye D, Signore A, Iannace C, Vangel M, Luongo A, Catalano M, Filomena M, Mansi L, Soricelli A, Salvatore M, Fuin N, Catana C, Mahmood U, Rosen BR.

Int J Oncol. 2017 Jul;51(1):281-288. doi: 10.3892/ijo.2017.4012. Epub 2017 May 19.


A phase one, single-dose, open-label, clinical safety and PET/MR imaging study of 68Ga-DOTATOC in healthy volunteers.

Esfahani SA, Salcedo S, Heidari P, Catalano OA, Pauplis R, Hesterman J, Kronauge JF, Mahmood U.

Am J Nucl Med Mol Imaging. 2017 Apr 15;7(2):53-62. eCollection 2017.


Permanent prostate brachytherapy postimplant magnetic resonance imaging dosimetry using positive contrast magnetic resonance imaging markers.

Martin GV, Pugh TJ, Mahmood U, Kudchadker RJ, Wang J, Bruno TL, Bathala T, Blanchard P, Frank SJ.

Brachytherapy. 2017 Jul - Aug;16(4):761-769. doi: 10.1016/j.brachy.2017.04.004. Epub 2017 May 10.


Select men benefit from androgen deprivation therapy delivered with salvage radiation therapy after prostatectomy.

Holliday EB, Kuban DA, Levy LB, Bolukbasi Y, Master P, Choi S, Nguyen Q, McGuire SE, Mahmood U, Frank SJ, Hoffman KE.

Prostate Cancer Prostatic Dis. 2017 Dec;20(4):389-394. doi: 10.1038/pcan.2017.24. Epub 2017 May 2.


Granzyme B PET Imaging as a Predictive Biomarker of Immunotherapy Response.

Larimer BM, Wehrenberg-Klee E, Dubois F, Mehta A, Kalomeris T, Flaherty K, Boland G, Mahmood U.

Cancer Res. 2017 May 1;77(9):2318-2327. doi: 10.1158/0008-5472.CAN-16-3346.


The declining utilization of brachytherapy for the treatment of prostate cancer: Can magnetic resonance imaging reverse the trend?

Mahmood U.

Brachytherapy. 2017 Jul - Aug;16(4):778-781. doi: 10.1016/j.brachy.2017.03.010. Epub 2017 Apr 29. Review.


A comparison of pediatric and adult CT organ dose estimation methods.

Gao Y, Quinn B, Mahmood U, Long D, Erdi Y, St Germain J, Pandit-Taskar N, Xu XG, Bolch WE, Dauer LT.

BMC Med Imaging. 2017 Apr 26;17(1):28. doi: 10.1186/s12880-017-0199-3.

Supplemental Content

Loading ...
Support Center